Amanote Research
Register
Sign In
Vitamin C Inactivates the Proteasome Inhibitor PS-341 in Human Cancer Cells
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-0503
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 1, 2006
Authors
W. Zou
Publisher
American Association for Cancer Research (AACR)
Related search
Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-Resistant Squamous Cell Carcinoma Cells by Induction of Noxa
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Nuclear Factor B Inhibitors Alleviate and the Proteasome Inhibitor PS-341 Exacerbates Radiation Toxicity in Zebrafish Embryos
Molecular Cancer Therapeutics
Cancer Research
Oncology
PS-341 and Histone Deacetylase Inhibitor Synergistically Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
PKC Regulates Death Receptor 5 Expression Induced by PS-341 Through ATF4-ATF3/CHOP Axis in Human Lung Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
PS-341 (Bortezomib) Induces Lysosomal Cathepsin B Release and a Caspase-2-Dependent Mitochondrial Permeabilization and Apoptosis in Human Pancreatic Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
Medicine
Genetics
Differential Sensitivity of Breast Cancer and Melanoma Cells to Proteasome Inhibitor Velcade
International Journal of Molecular Medicine
Medicine
Genetics
Synergistic Effect of Histone Deacetylase Inhibitors FK228 and M-Carboxycinnamic Acid Bis-Hydroxamide With Proteasome Inhibitors PSI and PS-341 Against Gastrointestinal Adenocarcinoma Cells
Clinical Cancer Research
Cancer Research
Oncology
Schiff Base Cu(II) Complexes as Inhibitors of Proteasome in Human Cancer Cells
Bratislava Medical Journal
